{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T23:04:57Z","timestamp":1762124697921,"version":"build-2065373602"},"reference-count":39,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100016259","name":"Mylan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016259","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014337","name":"Menarini Group","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014337","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001003","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001003","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006259","name":"Teva Pharmaceutical Industries","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006259","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009655","name":"Sunovion","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009655","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015351","name":"Pearl Therapeutics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015351","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","award":["CTT116855","NCT02164513"],"award-info":[{"award-number":["CTT116855","NCT02164513"]}],"id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal.chestnet.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chest"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.chest.2020.09.253","type":"journal-article","created":{"date-parts":[[2020,10,5]],"date-time":"2020-10-05T01:32:48Z","timestamp":1601861568000},"page":"985-995","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Effect of Age on the Efficacy and Safety of Once-Daily Single-Inhaler Triple-Therapy Fluticasone Furoate\/Umeclidinium\/Vilanterol in Patients With COPD"],"prefix":"10.1016","volume":"159","author":[{"given":"Nicola A.","family":"Hanania","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David M.","family":"Mannino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerard J.","family":"Criner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark T.","family":"Dransfield","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MeiLan K.","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. Elaine","family":"Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sally","family":"Kilbride","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David A.","family":"Lomas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neil","family":"Martin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando J.","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dave","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert A.","family":"Wise","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David M.G.","family":"Halpin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robson","family":"Lima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David A.","family":"Lipson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10159","key":"10.1016\/j.chest.2020.09.253_bib1","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1016\/S0140-6736(18)32203-7","article-title":"Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"392","year":"2018","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.chest.2020.09.253_bib2","first-page":"324","article-title":"National and state estimates of COPD morbidity and mortality: United States, 2014-2015","volume":"5","author":"Sullivan","year":"2018","journal-title":"Chronic Obstr Pulm Dis"},{"issue":"9589","key":"10.1016\/j.chest.2020.09.253_bib3","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/S0140-6736(07)61377-4","article-title":"International variation in the prevalence of COPD (the BOLD study): a population-based prevalence study","volume":"370","author":"Buist","year":"2007","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.chest.2020.09.253_bib4","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1159\/000067462","article-title":"Factors associated with increased risk of exacerbation and hospital admission in a cohort of ambulatory COPD patients: a multiple logistic regression analysis\u2014The EOLO Study Group","volume":"67","author":"Miravitlles","year":"2000","journal-title":"Respiration"},{"issue":"10","key":"10.1016\/j.chest.2020.09.253_bib5","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1136\/thx.2005.054924","article-title":"Admissions to hospital with exacerbations of chronic obstructive pulmonary disease: effect of age related factors and service organisation","volume":"61","author":"Connolly","year":"2006","journal-title":"Thorax"},{"issue":"4","key":"10.1016\/j.chest.2020.09.253_bib6","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1177\/2042098612443848","article-title":"Impact of prescribed medications on patient safety in older people","volume":"3","author":"Anathhanam","year":"2012","journal-title":"Ther Adv Drug Saf"},{"issue":"12","key":"10.1016\/j.chest.2020.09.253_bib7","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1001\/jama.2012.12422","article-title":"Caring for the older person with chronic obstructive pulmonary disease","volume":"308","author":"Fried","year":"2012","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.chest.2020.09.253_bib8","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1055\/s-0030-1265900","article-title":"COPD in the elderly patient","volume":"31","author":"Hanania","year":"2010","journal-title":"Semin Respir Crit Care Med"},{"issue":"5","key":"10.1016\/j.chest.2020.09.253_bib9","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1093\/gerona\/glv154","article-title":"Risk of frailty in elderly with COPD: a population-based study","volume":"71","author":"Lahousse","year":"2016","journal-title":"J\u00a0Gerontol A Biol Sci Med Sci"},{"issue":"1","key":"10.1016\/j.chest.2020.09.253_bib10","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.chest.2018.02.014","article-title":"The relationship between COPD and frailty: a systematic review and meta-analysis of observational studies","volume":"154","author":"Marengoni","year":"2018","journal-title":"Chest"},{"key":"10.1016\/j.chest.2020.09.253_bib11","first-page":"23","article-title":"Considerations for managing chronic obstructive pulmonary disease in the elderly","volume":"9","author":"Taffet","year":"2014","journal-title":"Clin Interv Aging"},{"issue":"7","key":"10.1016\/j.chest.2020.09.253_bib12","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1007\/s40266-018-0558-y","article-title":"Efficacy of umeclidinium\/vilanterol in elderly patients with COPD: a pooled analysis of randomized controlled trials","volume":"35","author":"Ray","year":"2018","journal-title":"Drugs Aging"},{"issue":"2","key":"10.1016\/j.chest.2020.09.253_bib13","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1093\/ageing\/afl174","article-title":"Inhaled therapy in elderly COPD patients: time for re-evaluation?","volume":"36","author":"Jarvis","year":"2007","journal-title":"Age Ageing"},{"issue":"4","key":"10.1016\/j.chest.2020.09.253_bib14","doi-asserted-by":"crossref","first-page":"745A","DOI":"10.1016\/j.chest.2018.08.673","article-title":"Ease and correct use of ELLIPTA by age in patients with asthma and COPD","volume":"154","author":"Sutton","year":"2018","journal-title":"Chest"},{"issue":"18","key":"10.1016\/j.chest.2020.09.253_bib15","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1056\/NEJMoa1713901","article-title":"Once-daily single-inhaler triple versus dual therapy in patients with COPD","volume":"378","author":"Lipson","year":"2018","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.chest.2020.09.253_bib16","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1183\/13993003.02165-2015","article-title":"A\u00a0phase III randomised controlled trial of single-dose triple therapy in COPD: the IMPACT protocol","volume":"48","author":"Pascoe","year":"2016","journal-title":"Eur Respir J"},{"issue":"4","key":"10.1016\/j.chest.2020.09.253_bib17","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.chest.2015.11.025","article-title":"Age-related differences in health-related quality of life in COPD: an analysis of the COPDGene and SPIROMICS cohorts","volume":"149","author":"Martinez","year":"2016","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.chest.2020.09.253_bib18","doi-asserted-by":"crossref","first-page":"1701393","DOI":"10.1183\/13993003.01393-2017","article-title":"Cigarette smoking and response to inhaled corticosteroids in COPD","volume":"51","author":"Bhatt","year":"2018","journal-title":"Eur Respir J"},{"issue":"9","key":"10.1016\/j.chest.2020.09.253_bib19","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/S2213-2600(19)30190-0","article-title":"Blood eosinophils and treatment response with triple and dual combination therapy in chronic obstructive pulmonary disease: analysis of the IMPACT trial","volume":"7","author":"Pascoe","year":"2019","journal-title":"Lancet Respir Med"},{"issue":"1","key":"10.1016\/j.chest.2020.09.253_bib20","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.chest.2016.08.1432","article-title":"Obesity is associated with increased morbidity in moderate to severe COPD","volume":"151","author":"Lambert","year":"2017","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.chest.2020.09.253_bib21","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1589\/jpts.29.658","article-title":"The change of lung capacity in elderly women caused by life span","volume":"29","author":"Lee","year":"2017","journal-title":"J\u00a0Phys Ther Sci"},{"issue":"3","key":"10.1016\/j.chest.2020.09.253_bib22","doi-asserted-by":"crossref","first-page":"253","DOI":"10.2147\/ciia.2006.1.3.253","article-title":"Effect of aging on respiratory system physiology and immunology","volume":"1","author":"Sharma","year":"2006","journal-title":"Clin Interv Aging"},{"issue":"1","key":"10.1016\/j.chest.2020.09.253_bib23","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1186\/s12890-018-0747-9","article-title":"Lung hyperinflation and functional exercise capacity in patients with COPD: a three-year longitudinal study","volume":"18","author":"Aalstad","year":"2018","journal-title":"BMC Pulm Med"},{"issue":"2","key":"10.1016\/j.chest.2020.09.253_bib24","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1513\/pats.200508-094DO","article-title":"Why does the lung hyperinflate?","volume":"3","author":"Ferguson","year":"2006","journal-title":"Proc Am Thorac Soc"},{"issue":"1","key":"10.1016\/j.chest.2020.09.253_bib25","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1136\/thx.2010.147041","article-title":"Forced vital capacity, airway obstruction and survival in a general population sample from the USA","volume":"66","author":"Burney","year":"2011","journal-title":"Thorax"},{"issue":"5","key":"10.1016\/j.chest.2020.09.253_bib26","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1183\/09031936.00042410","article-title":"Forced vital capacity paired with Framingham Risk Score for prediction of all-cause mortality","volume":"36","author":"Lee","year":"2010","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1016\/j.chest.2020.09.253_bib27","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1046\/j.1365-2125.2003.02007.x","article-title":"Age-related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications","volume":"57","author":"Mangoni","year":"2004","journal-title":"Br J Clin Pharmacol"},{"issue":"3","key":"10.1016\/j.chest.2020.09.253_bib28","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1183\/09031936.00193908","article-title":"Pneumonia risk in COPD patients receiving inhaled corticosteroids alone or in combination: TORCH study results","volume":"34","author":"Crim","year":"2009","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1016\/j.chest.2020.09.253_bib29","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.mcna.2011.11.003","article-title":"Age as a risk factor","volume":"96","author":"Dhingra","year":"2012","journal-title":"Med Clin North Am"},{"issue":"6","key":"10.1016\/j.chest.2020.09.253_bib30","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1111\/ggi.12823","article-title":"Parameters affecting inhalation therapy adherence in elderly patients with chronic obstructive lung disease and asthma","volume":"17","author":"Turan","year":"2017","journal-title":"Geriatr Gerontol Int"},{"key":"10.1016\/j.chest.2020.09.253_bib31","doi-asserted-by":"crossref","first-page":"495","DOI":"10.2147\/COPD.S32674","article-title":"Practical aspects of inhaler use in the management of chronic obstructive pulmonary disease in the primary care setting","volume":"7","author":"Yawn","year":"2012","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"issue":"6","key":"10.1016\/j.chest.2020.09.253_bib32","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1089\/jamp.2015.1223","article-title":"The ELLIPTA(R) dry powder inhaler: design, functionality, in\u00a0vitro dosing performance and critical task compliance by patients and caregivers","volume":"28","author":"Grant","year":"2015","journal-title":"J\u00a0Aerosol Med Pulm Drug Deliv"},{"issue":"1","key":"10.1016\/j.chest.2020.09.253_bib33","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/s12890-018-0662-0","article-title":"Comparison of peak inspiratory flow rate via the Breezhaler(R), Ellipta(R) and HandiHaler(R) dry powder inhalers in patients with moderate to very severe COPD: a randomized cross-over trial","volume":"18","author":"Altman","year":"2018","journal-title":"BMC Pulm Med"},{"issue":"6","key":"10.1016\/j.chest.2020.09.253_bib34","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1089\/jamp.2015.1224","article-title":"Effect of disease severity in asthma and chronic obstructive pulmonary disease on inhaler-specific inhalation profiles through the ELLIPTA(R) dry powder inhaler","volume":"28","author":"Prime","year":"2015","journal-title":"J\u00a0Aerosol Med Pulm Drug Deliv"},{"issue":"4","key":"10.1016\/j.chest.2020.09.253_bib35","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.rmed.2007.11.003","article-title":"Effect of incorrect use of dry powder inhalers on management of patients with asthma and COPD","volume":"102","author":"Lavorini","year":"2008","journal-title":"Respir Med"},{"key":"10.1016\/j.chest.2020.09.253_bib36","doi-asserted-by":"crossref","first-page":"17001","DOI":"10.1038\/npjpcrm.2017.1","article-title":"A\u00a0randomised open-label cross-over study of inhaler errors, preference and time to achieve correct inhaler use in patients with COPD or asthma: comparison of ELLIPTA with other inhaler devices","volume":"27","author":"van der Palen","year":"2017","journal-title":"NPJ Prim Care Respir Med"},{"issue":"6","key":"10.1016\/j.chest.2020.09.253_bib37","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.rmed.2011.01.005","article-title":"Inhaler mishandling remains common in real life and is associated with reduced disease control","volume":"105","author":"Melani","year":"2011","journal-title":"Respir Med"},{"key":"10.1016\/j.chest.2020.09.253_bib38","doi-asserted-by":"crossref","first-page":"597","DOI":"10.2147\/COPD.S103335","article-title":"Inhalation errors due to device switch in patients with chronic obstructive pulmonary disease and asthma: critical health and economic issues","volume":"11","author":"Roggeri","year":"2016","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"issue":"146","key":"10.1016\/j.chest.2020.09.253_bib39","doi-asserted-by":"crossref","first-page":"170055","DOI":"10.1183\/16000617.0055-2017","article-title":"Inhaler technique: does age matter? A systematic review","volume":"26","author":"Barbara","year":"2017","journal-title":"Eur Respir Rev"}],"container-title":["Chest"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369220348467?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369220348467?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T23:01:51Z","timestamp":1762124511000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369220348467"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["S0012369220348467"],"URL":"https:\/\/doi.org\/10.1016\/j.chest.2020.09.253","relation":{},"ISSN":["0012-3692"],"issn-type":[{"type":"print","value":"0012-3692"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of Age on the Efficacy and Safety of Once-Daily Single-Inhaler Triple-Therapy Fluticasone Furoate\/Umeclidinium\/Vilanterol in Patients With COPD","name":"articletitle","label":"Article Title"},{"value":"Chest","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chest.2020.09.253","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier Inc under license from the American College of Chest Physicians.","name":"copyright","label":"Copyright"}]}}